Department of Pathology & Laboratory Medicine, University of Calgary and Alberta Precision Laboratories (APL), Calgary, Alberta, Canada;
Department of Pathology & Laboratory Medicine, University of Calgary and Alberta Precision Laboratories (APL), Calgary, Alberta, Canada.
Anticancer Res. 2023 Nov;43(11):4801-4807. doi: 10.21873/anticanres.16677.
BACKGROUND/AIM: B-cell lymphomas are characterized by diverse genetic anomalies affecting B-cell differentiation. To expand targeted therapies, an in-depth grasp of the molecular dynamics in the germinal center (GC) is vital. Transducin β-like 1 X-linked receptor 1 (TBL1XR1) and nuclear receptor corepressor 1 (NCOR1) are instrumental within the GC, modulating myriad oncogenic pathways. Their prognostic roles in various cancers are established, yet their precise impact on B-cell lymphoma is elusive.
Digital RNA quantification (Nanostring) of previously curated 188 B-cell lymphoma specimens across four subtypes, follicular lymphoma (FL), diffuse large B-cell lymphoma, not otherwise specified (DLBCL-NOS), primary testicular lymphoma (PTL), and plasmablastic lymphoma (PBL), was reanalyzed with focus on TBL1XR1 and NCOR1 expression, juxtaposing them with 730 ontogenically linked genes.
Notably, TBL1XR1 expression was significantly elevated in the PTL- ABC-subtype versus DLBCL-NOS- ABC-subtype (p<0.001), with no marked disparity in GCB-subtypes between them. The median TBL1XR1 expression was remarkably diminished in FL, yet, intriguingly, GCB-subtypes of DLBCL-NOS exhibited significantly enhanced expression compared to FL (p=0.001). In contrast, NCOR1's expression trajectory was consistent across DLBCL-NOS, PTL, and PBL. A strong inverse correlation between TBL1XR1 and NCOR1 was observed in PBL (p=0.001). Importantly, TBL1XR1's pronounced association with several DNA Damage repair (DDR) genes was noted suggesting influence on DNA repair. TBL1XR1-DDR gene signature was further validated employing a public data set of DLBCL-NOS.
Our exploratory findings unravel the expression patterns of TBL1XR1/NCOR1 in B-cell lymphoma variants. The TBL1XR1-DDR genes connection offers insights into potential DNA repair roles, paving avenues for innovative therapies in B-cell lymphomas.
背景/目的:B 细胞淋巴瘤的特征是存在影响 B 细胞分化的多种遗传异常。为了扩大靶向治疗,深入了解生发中心(GC)的分子动力学至关重要。转导素β样 1 X 连锁受体 1(TBL1XR1)和核受体共抑制因子 1(NCOR1)在 GC 中起着重要作用,调节着众多致癌途径。它们在各种癌症中的预后作用已得到确立,但它们对 B 细胞淋巴瘤的确切影响尚不清楚。
对以前经过策展的 188 例 B 细胞淋巴瘤标本进行数字 RNA 定量(Nanostring),这些标本分为四个亚型:滤泡性淋巴瘤(FL)、弥漫性大 B 细胞淋巴瘤、非特指型(DLBCL-NOS)、原发性睾丸淋巴瘤(PTL)和浆母细胞淋巴瘤(PBL),重点分析 TBL1XR1 和 NCOR1 的表达,并将其与 730 个同源基因进行比较。
值得注意的是,在 PTL-ABC 亚型与 DLBCL-NOS-ABC 亚型相比,TBL1XR1 的表达显著升高(p<0.001),而它们之间的 GCB 亚型之间没有明显差异。FL 中的 TBL1XR1 表达明显降低,但有趣的是,DLBCL-NOS 的 GCB 亚型与 FL 相比表达显著增强(p=0.001)。相反,NCOR1 的表达轨迹在 DLBCL-NOS、PTL 和 PBL 之间是一致的。在 PBL 中观察到 TBL1XR1 和 NCOR1 之间存在强烈的负相关(p=0.001)。重要的是,TBL1XR1 与多个 DNA 损伤修复(DDR)基因的显著关联表明其对 DNA 修复的影响。TBL1XR1-DDR 基因特征进一步通过 DLBCL-NOS 的公共数据集得到验证。
我们的探索性发现揭示了 TBL1XR1/NCOR1 在 B 细胞淋巴瘤变异体中的表达模式。TBL1XR1-DDR 基因的联系提供了对潜在 DNA 修复作用的深入了解,为 B 细胞淋巴瘤的创新治疗开辟了途径。